|
Volumn 363, Issue 23, 2010, Pages 2228-2232
|
Innovation, regulation, and the FDA
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIETHYLSTILBESTROL;
THIORIDAZINE;
CONFERENCE PAPER;
DRUG INDUSTRY;
FOOD AND DRUG ADMINISTRATION;
GENERAL PRACTITIONER;
HEALTH CARE;
INSOMNIA;
LAW SUIT;
MEDICAL PRACTICE;
MEDICAL RESEARCH;
MEDICINE;
PEER REVIEW;
PRIORITY JOURNAL;
SPONTANEOUS ABORTION;
ARTICLE;
CIVIL RIGHTS;
DRUG CONTROL;
DRUG LEGISLATION;
GOVERNMENT REGULATION;
HISTORY;
LAW;
LEGAL ASPECT;
MARKETING;
TOBACCO INDUSTRY;
UNITED STATES;
CIVIL RIGHTS;
DRUG AND NARCOTIC CONTROL;
DRUG INDUSTRY;
GOVERNMENT REGULATION;
HISTORY, 20TH CENTURY;
LEGISLATION, DRUG;
LEGISLATION, FOOD;
MARKETING;
TOBACCO INDUSTRY;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 78649744911
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMsa1007467 Document Type: Conference Paper |
Times cited : (52)
|
References (16)
|